NCT04014374View on ClinicalTrials.gov

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

RecruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

September 10, 2019

Primary Completion Date

February 28, 2030

Study Completion Date

February 28, 2030

Conditions

Leukemia/LymphomaCutaneous T Cell LymphomaATLL

Trial Locations (1)

53226

RECRUITING

CIBMTR, Milwaukee

Sponsors

Lead Sponsor

Kyowa Kirin, Inc.

All Listed Sponsors

lead

Kyowa Kirin, Inc.

INDUSTRY